/ Print /

HOSPITAL & PROVIDER STRATEGY

CMS plan to slash 340B payments under fire by hospitalsHere are four ways CMS’ final rule related to the 340B Drug Pricing Program could affect the healthcare industry.
‘Encouraging’ COPD drug pipeline could ease symptoms, address root causesAlbert A. Rizzo, MD, senior medical advisor for the American Lung Association, says the increasing number of drugs in the pipeline could improve airflow address the underlying disease process.
Three ways to help nurses advance your population health initiativesWidespread adoption of population-focused nursing practice will likely take place over the next five to 10 years. Here’s how to stay ahead of the curve.
Don’t let your tools to curb the opioid epidemic go to wasteNew public opinion survey about opioid use from Prime Therapeutics has surprising results.
Unique payer-provider cancer treatment partnershipsUnique partnerships between payers and providers focus on keeping patients out of the hospital and on the road to remission.
Managing cancer treatment side effects: What payers should knowMoffitt Cancer Center expert shares her thinking on managing chemotherapy-related side effects.
COPD patient education needs, challenges: What health execs should knowEducation is a significant element of comprehensive care for COPD patients. In this Q&A, one expert shares her recommendations.
Potential CVS-Aetna merger: Key takeaways for health execsThe CVS Health-Aetna potential merger will have healthcare executives rethinking traditional industry competitors. Here’s why.
Six healthcare interoperability barriers to watch
Six healthcare interoperability barriers to watchIs interoperability in healthcare a dream, or will payers, providers, and technology vendors finally come together to make data more available to one another?
Five ACO success tips from Beth Israel Deaconess Care Organization CEOFind out what worked for this value-based physician and hospital network and Accountable Care Organization in Massachusetts.